| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 24,332 | 6,939 |
| Increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents | 4,162 | -5,840 |
| Effect of exchange rate changes on cash | -19 | - |
| Cash and cash equivalents at beginning of period | 27,764 | - |
| Cash and cash equivalents at end of period | 31,907 | - |
DarioHealth Corp. (DRIO)
DarioHealth Corp. (DRIO)